Development of Oral, Potent, and Selective CK1α Degraders for AML TherapyLu Huang, Wenchao Lu, Yanli Sun et al.|JACS Au|2024Cited by 16
Identification and validation of ubiquitination-related signature and subgroups in immune microenvironment of tuberculosisPeipei Zhou, Zhenpeng Li, Jie Shen et al.|Aging|2023Cited by 3